| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.7 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |